Dr. Jankowitz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Civic Center Blvd
# 15
Philadelphia, PA 19104Phone+1 215-662-3487Fax+1 856-968-7410
Education & Training
- Lewis Katz School of Medicine at Temple UniversityClass of 2003
Certifications & Licensure
- NJ State Medical License 2003 - 2025
- PA State Medical License 2019 - 2024
- American Board of Neurological Surgery Neurological Surgery
Clinical Trials
- Stereotactic, Robot-assisted Intracerebral Hemorrhage Clot Evacuation Start of enrollment: 2020 Sep 30
Publications & Presentations
PubMed
- 66 citationsSafety and efficacy of thrombectomy in acute ischaemic stroke (REVASCAT): 1-year follow-up of a randomised open-label trialAntoni Dávalos, Erik Cobo, Carlos A. Molina, Ángel Chamorro, M Angeles de Miquel
The Lancet. Neurology. 2017-05-01 - 4176 citationsRandomized Assessment of Rapid Endovascular Treatment of Ischemic StrokeMayank Goyal, Muneer Eesa, John Thornton, Denis-Claude Roy, Dar Dowlatshahi
The New England Journal of Medicine. 2015-03-11 - 18 citationsRobotic Stereotactic Assistance (ROSA) Utilization for Minimally Invasive Placement of Intraparenchymal Hematoma and Intraventricular Catheters.Nima Alan, Phillip Lee, Alp Ozpinar, Bradley A. Gross, Brian T. Jankowitz
World Neurosurgery. 2017-12-01
Press Mentions
- Rapid Medical Receives FDA Breakthrough Device Designation for Vasospasm TreatmentFebruary 15th, 2022
- Rapid Medical’s Comaneci Embolization Assist Device Receives FDA Breakthrough Designation to Treat Cerebral VasospasmFebruary 15th, 2022
- Rapid Medical Obtains FDA Breakthrough Device Designation for ComaneciFebruary 17th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: